BioCentury
ARTICLE | Financial News

Relypsa raises $150M in follow-on

February 27, 2015 2:10 AM UTC

Metabolic and renal play Relypsa Inc. (NASDAQ:RLYP) raised $150.2 million through the sale of 3.9 million shares at $38.50. BofA Merrill Lynch; Cowen; Oppenheimer; Stifel; and Wedbush PacGrow were underwriters. Relypsa proposed the offering after market close on Tuesday when its shares were valued at $38.27.

Relypsa's NDA for patiromer to treat hyperkalemia is under FDA review. The PDUFA date for the high-capacity oral potassium binder is Oct. 21. ...